Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: A therapeutic potential strategy for keloid

Archives of Dermatological Research

Volumn 300, Issue 4, 2008, Pages 177-184

  Zhang, Guo You ^a   Yi, Cheng Gang ^b   Li, Xuan ^a   Zheng, Yan ^b   Niu, Zhan Guo ^a   Xia, Wei ^b   Meng, Zhou ^a   Meng, Cheng Yue ^a   Guo, Shu Zhong ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Gene therapy; Keloid; Plasminogen activator inhibitor 1; Vascular endothelial growth factor

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; SMALL INTERFERING RNA; VASCULOTROPIN;

ADOLESCENT; ADULT; ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KELOID; MALE; NONVIRAL GENE THERAPY; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CELLS, CULTURED; DOWN-REGULATION; FEMALE; FIBROBLASTS; GENE THERAPY; GENETIC VECTORS; HUMANS; KELOID; MALE; NEOVASCULARIZATION, PATHOLOGIC; PLASMIDS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA INTERFERENCE; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41049111945     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-007-0825-y     Document Type: Article

References (35)

1. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553
2. Brummelkamp TR, Bernards R, Agami R (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2:243-247
3. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
4. Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, Yoon SS (2005) Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer Res 13:5881-5889
5. Diegelmann RF, Cohen IK, McCoy BJ (1979) Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro. J Cell Physiol 98:341-346
6. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, Kapanci Y, Gabbiani G (1994) Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145:105-113
7. Ferrara N, Houck K, Jakeman L, Leung DW (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32
8. Gira AK, Brown LF, Washington CV, Cohen C, Arbiser JL (2004) Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor. J Am Acad Dermatol 50:850-853
9. Hasuwa H, Kaseda K, Einarsdottir T, Okabe M (2002) Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett 532:227-230
10. Henschel A, Buchholz F, Habermann B (2004) DEQOR: a web-based tool for the design and quality control of siRNAs. Nucleic Acids Res 32:W113-W120
11. Le AD, Zhang Q, Wu Y, Messadi DV, Akhondzadeh A, Nguyen AL, Aghaloo TL, Kelly AP, Bertolami CN (2004) Elevated vascular endothelial growth factor in keloids: relevance to tissue fibrosis. Cells Tissues Organs 176:87-94
12. Matsumoto G, Kushibiki T, Kinoshita Y, Lee U, Omi Y, Kubota E, Tabata Y (2006) Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma. Cancer Sci 97:313-321
13. Miyagishi M, Taira K (2002) U6-promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression inmammalian cells. Nat Biotechnol 20:497-500
14. Murray JC (1994) Keloids and hypertrophic scars. Clin Dermatol 2:27-37
15. Oloffson B, Korpelainen E, PeppersMS, Mandriota SJ, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K, Eriksson U (1998)Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 95:11709-11714
16. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16:948-958
17. Paul CP, Good PD, Winer I, Engelke DR (2002) Effective expression of small interfering RNA in human cells. Nat Biotechnol 20:505-508
18. Pepper MS, Ferrara N, Orci L, Montesano R (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902-906
19. Rahban SR, Garner WL (2003) Fibroproliferative scars. Clin Plast Surg 30:77-89
20. Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, Bennett J, Tolentino MJ (2003) Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 9:210-216
21. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22:326-330
22. Sayah DN, Soo C, Shaw WW, Watson J, Messadi D, Longaker MT, Zhang X, Ting K (1999) Down-regulation of apoptosis-related genes in keloid tissues. J Surg Res 87:209-216
23. Shi Y (2003) Mammalian RNAi forthe masses. Trends Genet 19:9-12
24. Steinbrech DS, Mehrara BJ, Chau D, Rowe NM, Chin G, Lee T, Saadeh PB, Gittes GK, Longaker MT (1999) Hypoxia upregulates VEGF production in keloid fibroblasts. Ann Plast Surg 42:514-519
25. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC, Shi Y (2002) A DNA vector-based RNAi technology to suppress expression in mammalian cells. Proc Natl Acad Sci USA 99:5515-5520
26. Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T (2004) A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 64:3365-3370
27. Thomas KA (1996) Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271:603-606
28. Tiscornia G, Singer O, Ikawa M, Verma IM (2003) A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 110:1844-1848
29. Tuan TL, Nichter LS (1998) The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4:19-24
30. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, Laug WE (1996) Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 106:1007-1011
31. Tuan TL, Wu HY, Hang EY, Chong SS, Laug W, Messadi D, Kelly P, Le A (2003) Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 162:1579-1589
32. Wu Y, Zhang Q, Ann DK, Akhondzadeh A, Duong HS, Messadi DV, Le AD (2004) Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol 286:C905-C912
33. Yoshimoto H, Ishihara H, Ohtsuru A, Akino K, Murakami R, Kuroda H, Namba H, Ito M, Fujii T, Yamashita S (1999) Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 154:883-889
34. Zhang Q, Wu Y, Chau C, Ann DK, Bertolami CN, Le AD (2004) Cross talk of hypoxia mediated signaling pathways in upregulation plasminogen activator inhibitor-1 expression in keloid fibroblasts. J Cell Physiol 199:89-97
35. Zhang QZ, Wu YD, Ann DK, Messadi DV, Tuan TL, Kelly AP, Bertolami CN, Le AD (2003) Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 121:1005-1012